- Home
- CRT vs ASRT Comparison
CRT vs ASRT Comparison
Compare CRT & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRT | ASRT |
|---|---|---|
| Founded | 1991 | 1995 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.1M | 76.0M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | CRT | ASRT |
|---|---|---|
| Price | $10.51 | $23.44 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 21.1K | ★ 418.0K |
| Earning Date | 04-14-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $118,713,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.85 |
| P/E Ratio | $11.55 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.07 | $0.60 |
| 52 Week High | $11.10 | $23.46 |
Technical Indicators
Market Signals| Indicator | CRT | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 87.46 |
| Support Level | $10.05 | $0.70 |
| Resistance Level | $11.08 | N/A |
| Average True Range (ATR) | 0.33 | 0.18 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 85.14 | 98.66 |
Price Performance
Historical ComparisonAbout CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.